News Headlines Article

CMS approves Washington plan for hepatitis C drug subscription deals
Modern Healthcare

Washington became the fourth state to win a Medicaid state plan amendment allowing it to negotiate value-based purchasing agreements with prescription drug manufacturers.

The CMS announced Wednesday that it approved Washington’s proposal to let the state negotiate under a subscription model with makers of costly hepatitis C drugs. Under that model, the state would pay a fixed annual amount to a manufacturer to buy an unrestricted supply of hepatitis C drugs.